Independent impact of periodontitis and cardiovascular disease on elevated soluble urokinase‐type plasminogen activator receptor (suPAR) levels

G Isola, A Polizzi, A Alibrandi… - Journal of …, 2021 - Wiley Online Library
Background Previous studies have demonstrated that a soluble urokinase‐type
plasminogen activator receptor (suPAR) plays an essential function in leukocytes and …

Soluble urokinase plasminogen activator receptor is associated with inflammation in the vulnerable human atherosclerotic plaque

A Edsfeldt, M Nitulescu, H Grufman, C Grönberg… - Stroke, 2012 - Am Heart Assoc
Background and Purpose—Recently, plasma soluble urokinase plasminogen activator
receptor (suPAR) has gained interest as a marker of cardiovascular risk. suPAR is released …

Soluble urokinase plasminogen activator receptor: a risk factor for carotid plaque, stroke, and coronary artery disease

M Persson, G Östling, G Smith, V Hamrefors… - Stroke, 2014 - Am Heart Assoc
Background and Purpose—Recent studies indicate that the urokinase system could have an
important role in atherogenesis and plaque rupture. The relationships among the soluble …

[HTML][HTML] Soluble urokinase plasminogen activator receptor (suPAR) as a biomarker of systemic chronic inflammation

LJH Rasmussen, JEV Petersen… - Frontiers in …, 2021 - frontiersin.org
Systemic chronic inflammation (SCI) is persistent, health-damaging, low-grade inflammation
that plays a major role in immunosenescence and in development and progression of many …

Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmö Diet and Cancer Study

M Persson, G Engström, H Björkbacka, B Hedblad - Atherosclerosis, 2012 - Elsevier
BACKGROUND: Soluble urokinase plasminogen activator receptor (suPAR) is a highly
sensitive marker that reflects increased inflammation and is positively correlated with pro …

Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population

J Eugen‐Olsen, O Andersen… - Journal of internal …, 2010 - Wiley Online Library
Eugen‐Olsen J, Andersen O, Linneberg A, Ladelund S, Hansen TW, Langkilde A, Petersen
J, Pielak T, Møller LN, Jeppesen J, Lyngbæk S, Fenger M, Olsen MH, Hildebrandt PR, Borch …

[HTML][HTML] Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis

G Hindy, DJ Tyrrell, A Vasbinder, C Wei… - The Journal of …, 2022 - Am Soc Clin Investig
People with kidney disease are disproportionately affected by atherosclerosis for unclear
reasons. Soluble urokinase plasminogen activator receptor (suPAR) is an immune-derived …

Risk factors associated with serum levels of the inflammatory biomarker soluble urokinase plasminogen activator receptor in a general population

TH Haupt, T Kallemose, S Ladelund… - Biomarker …, 2014 - journals.sagepub.com
The soluble urokinase plasminogen activator receptor (suPAR) is a biomarker of mortality
risk in various patient populations. However, little is known about the implications of lifestyle …

Soluble urokinase plasminogen activator receptor level is an independent predictor of the presence and severity of coronary artery disease and of future adverse …

DJ Eapen, P Manocha, N Ghasemzadeh… - Journal of the …, 2014 - Am Heart Assoc
Introduction Soluble urokinase plasminogen activator receptor (suPAR) is an emerging
inflammatory and immune biomarker. Whether suPAR level predicts the presence and the …

Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events

T Sehestedt, S Lyngbaek, J Eugen-Olsen, J Jeppesen… - Atherosclerosis, 2011 - Elsevier
OBJECTIVE: The soluble urokinase plasminogen activator receptor (suPAR) is a plasma
marker of low grade inflammation and has been associated with cardiovascular risk. We …